BNP Paribas Financial Markets’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-9,800
| Closed | -$1.87K | – | 5789 |
|
|
2025
Q3 | $1.87K | Sell |
9,800
-261,395
| -96% | -$313K | ﹤0.01% | 5175 |
|
|
2025
Q2 | $461K | Buy |
271,195
+35,794
| +15% | +$60.4K | ﹤0.01% | 3371 |
|
|
2025
Q1 | $372K | Buy |
235,401
+70,806
| +43% | +$120K | ﹤0.01% | 3340 |
|
|
2024
Q4 | $295K | Buy |
164,595
+120,100
| +270% | +$382K | ﹤0.01% | 3650 |
|
|
2024
Q3 | $270K | Buy |
44,495
+900
| +2% | +$4.94K | ﹤0.01% | 3129 |
|
|
2024
Q2 | $229K | Buy |
43,595
+1,100
| +3% | +$6.99K | ﹤0.01% | 3053 |
|
|
2024
Q1 | $361K | Sell |
42,495
-14,971
| -26% | -$131K | ﹤0.01% | 3017 |
|
|
2023
Q4 | $379K | Buy |
57,466
+35,771
| +165% | +$176K | ﹤0.01% | 2947 |
|
|
2023
Q3 | $67K | Buy |
21,695
+7,290
| +51% | +$21K | ﹤0.01% | 3413 |
|
|
2023
Q2 | $38.9K | Buy |
14,405
+4,976
| +53% | +$14.6K | ﹤0.01% | 3527 |
|
|
2023
Q1 | $28K | Buy |
9,429
+7,929
| +529% | +$23.3K | ﹤0.01% | 3494 |
|
|
2022
Q4 | $3.78K | Buy |
+1,500
| New | +$4.31K | ﹤0.01% | 3689 |
|
|
2022
Q2 | – | Sell |
-792
| Closed | -$4.89K | – | 4131 |
|
|
2022
Q1 | $4.89K | Buy |
792
+736
| +1,314% | +$6.47K | ﹤0.01% | 3855 |
|
|
2021
Q4 | $795 | Sell |
56
-397
| -88% | -$4.42K | ﹤0.01% | 4071 |
|
|
2021
Q3 | $3.62K | Buy |
453
+22
| +5% | +$350 | ﹤0.01% | 3738 |
|
|
2021
Q2 | $12.3K | Buy |
+431
| New | +$12.5K | ﹤0.01% | 3670 |
|
BNP Paribas Financial Markets's EPIX Position: Q4 2025 in Review
BNP Paribas Financial Markets sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 9,800 shares — an estimated $1.87K sold.
BNP Paribas Financial Markets first reported a position in EPIX in Q2 2021 and held it in 16 quarters. The position peaked at $461K in Q2 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- BNP Paribas Financial Markets reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 9,800 ESSA Pharma shares in Q4 2025, an estimated $1.87K.
- BNP Paribas Financial Markets first reported a position in ESSA Pharma in Q2 2021 and held it in 16 quarters.
- BNP Paribas Financial Markets's ESSA Pharma position peaked at $461K in Q2 2025.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.